News

Effective strategies for managing child agitation focus on individualized care, multidisciplinary support, and proactive interventions to ensure safety and calm.

Researchers uncover how serotonin receptor 5-HT1A influences drug interactions, paving the way for faster, targeted psychiatric treatments.

New executive order targets homeless individuals through institutionalization, raising concerns about stigma and lack of real solutions for vulnerable populations.

Explore the intersection of psychiatry and politics as H. Steven Moffic, MD, reflects on Canadian unity and the challenges facing mental health services today.

Explore the evolution and therapeutic potential of GLP-1, a key incretin in diabetes management and weight loss solutions.

UK study of "active ingredients" in early psychosis intervention is applicable to US programs, according to the codirector of Stanford's INSPIRE Clinic.

NRx Pharmaceuticals secures FDA Fast Track designation for NRX-100, a preservation-free formulation of intravenous ketamine for suicidal ideation in depression.

Let's examine the mental health challenges faced by Native Americans and First Nations, highlighting historical trauma and the need for reparative actions.

Stay updated on key psychopharmacology developments, including new treatments for schizophrenia and breakthroughs in depression therapy.

The FDA has granted a Type C Meeting to Nutriband for their Aversa fentanyl patch, which aims to revolutionize pain management with its innovative abuse-deterrent technology.

Let's examine innovative psychiatric approaches to address social conflicts, such as empathy, understanding, and the potential for healing in turbulent times.

Youth with neurodevelopmental disorders face significant suicide risks.

Boehringer Ingelheim and Click Therapeutics achieve breakthrough results in treating negative schizophrenia symptoms with investigational prescription digital therapeutic CT-155.

Serum drug levels provide crucial insights for optimizing psychiatric treatment, enhancing patient outcomes in cases of schizophrenia and OCD.

What are the parallels between train travel and psychiatric care?

We want to emphasize the importance of diversity in mental health care, offering resources to enhance culturally informed practices for all clinicians.

Adial Pharmaceuticals just wrapped a successful end of phase 2 meeting with the FDA and will now advance its innovative treatment for alcohol use disorder, AD04.

Extreme heat poses serious health risks, especially for vulnerable populations. Learn essential tips to help patients stay safe during heat waves and protect their well-being.

Benzodiazepines spark ongoing debate, balancing effective anxiety relief with addiction risks, as cultural attitudes shape their use and perception.

Explore the intersection of art and war, revealing how artists can uniquely interpret conflict and enhance mental health care through creative expression.

Exploring the impact of fermented foods like sauerkraut on social anxiety, revealing surprising insights and practical solutions for mental health.

Emergency departments face unique challenges with malingering patients, requiring compassionate communication and understanding to navigate complex interactions effectively.

Learn more about effective strategies for managing obesity and metabolic dysfunction in schizophrenia, focusing on dietary interventions and pharmacological treatments.

The themes of forgiveness and redemption in Shakespeare and contemporary plays highlight their impact on mental health and societal healing.

Our August theme: the complexities of ADHD, including assessment, treatment options, and comorbidities. Share your insights!

Explore the psychological depths of Macbeth's ambition and its destructive consequences, reflecting on leadership challenges in today's society.

These 2 memoirs delve into mental health, revealing the complexities of personal struggles and the pursuit of self-acceptance.

Biogen's zuranolone gains positive opinion for treating postpartum depression, promising rapid symptom relief and potential EU approval by 2025.

Check out the pipeline updates from July!